Lexicon Pharmaceuticals, Inc. (formerly Lexicon Genetic) a biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of human disease, including immunology, metabolism, cardiology, and ophthalmology. The company's drug candidates include LX1031, which has completed Phase II clinical trials for the treatment of irritable bowel syndrome and other gastrointestinal disorders; LX4211 that has completed Phase II clinical trials to treat type 2 diabetes; LX2931, which is in Phase II clinical trials for the treatment of rheumatoid arthritis and other autoimmune diseases; and LX1032 that has completed Phase II clinical trials to treat the symptoms associated with carcinoid syndrome. It also has a preclinical development drug candidate, LX7101, for the treatment of glaucoma. The company has drug discovery alliances with Bristol-Myers Squibb Company; Genentech, Inc.; N.V. Organon; and Takeda Pharmaceutical Company Limited. It also has drug development financing collaboration with Symphony Icon; collaboration agreement with Taconic Farms, Inc.; and an alliance with Nuevolution A/S, which provides access to Nuevolution's Chemetics platform chemistry technology.The staff at Lexicon Pharmaceuticals come from unusually diverse demographic backgrounds. The company is 42.0% female and 50.4% ethnic minorities. Despite its diversity in other areas, Lexicon Pharmaceuticals employees are noticeably lacking in political diversity. It has an unusually high proportion of employees who are members of the Democratic Party, at 78.0%. Employees seem to enjoy working in an otherwise diverse workplace that is dominated by members of the Democratic Party. Lexicon Pharmaceuticals has great employee retention with staff members usually staying with the company for 6.4 years.The average employee at Lexicon Pharmaceuticals makes $81,955 per year. In comparison, some of its highest paying competitors, like Yumanity Therapeutics, PTC Therapeutics, and Merrimack Pharmaceuticals, pay $96,863, $92,986, and $90,170, respectively.Based in Texas, Lexicon Pharmaceuticals is a small pharmaceutical company with only 225 employees and an annual revenue of $31.1M.
Lexicon Pharmaceuticals's mission statement
To pioneer medicines that transform patients lives.
In demand companies are hiring! Let Zippia apply for you!
-
Lexicon Pharmaceuticals employee reviews
Be the first to review!
Do you work at Lexicon Pharmaceuticals?
Help job seekers learn about working at Lexicon Pharmaceuticals
The founders of Lexicon Pharmaceuticals is Arthur Sands.
The key people at Lexicon Pharmaceuticals are Lonnel Coats and Arthur Sands.
Key people
Lonnel Coats
Arthur Sands
Lexicon Pharmaceuticals rankings
Lexicon Pharmaceuticals is ranked #81 on the Best Pharmaceutical companies to work for in America list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
Rate Lexicon Pharmaceuticals' promotion and raise policies.
Lexicon Pharmaceuticals diversity
9.6
Diversity score
We calculated Lexicon Pharmaceuticals’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Lexicon Pharmaceuticals’s workforce.
Lexicon Pharmaceuticals diversity summary. Zippia estimates Lexicon Pharmaceuticals's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated Lexicon Pharmaceuticals's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Lexicon Pharmaceuticals's workforce.
Lexicon Pharmaceuticals has 225 employees.
42% of Lexicon Pharmaceuticals employees are women, while 58% are men.
The most common ethnicity at Lexicon Pharmaceuticals is White (50%).
20% of Lexicon Pharmaceuticals employees are Asian.
16% of Lexicon Pharmaceuticals employees are Hispanic or Latino.
The average employee at Lexicon Pharmaceuticals makes $81,955 per year.
Lexicon Pharmaceuticals employees are most likely to be members of the democratic party.
Employees at Lexicon Pharmaceuticals stay with the company for 6.4 years on average.
Do you work at Lexicon Pharmaceuticals?
Is Lexicon Pharmaceuticals' workforce diverse and inclusive?
Lexicon Pharmaceuticals office locations
Lexicon Pharmaceuticals is headquartered in The Woodlands, TX
Lexicon Pharmaceuticals financial performance
9.6
Performance score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.
Lexicon Pharmaceuticals currently has 139.0K in revenue. Lexicon Pharmaceuticals's most recent quarter produced 317.0k (q2'2023).
Compare Lexicon Pharmaceuticals salaries to competitors, including Yumanity Therapeutics, PTC Therapeutics, and Merrimack Pharmaceuticals. Employees at Yumanity Therapeutics earn the highest average yearly salary of $96,863. The salaries at PTC Therapeutics average $92,986 per year, and the salaries at Merrimack Pharmaceuticals come in at $90,170 per year.
Rank
Company
Average salary
Jobs
1
$96,863
0
2
$92,986
0
3
$90,170
0
4
$83,155
0
5
$81,022
0
6
$81,014
0
7
$76,894
0
8
$76,714
0
9
$75,211
0
10
$74,270
0
Show more
Are you an executive, HR leader, or brand manager at Lexicon Pharmaceuticals?
Claiming and updating your company profile on Zippia is free and easy.
Lexicon Pharmaceuticals FAQs
When was Lexicon Pharmaceuticals founded?
How many employees does Lexicon Pharmaceuticals have?
Zippia gives an in-depth look into the details of Lexicon Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Lexicon Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Lexicon Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Lexicon Pharmaceuticals. The data presented on this page does not represent the view of Lexicon Pharmaceuticals and its employees or that of Zippia.
Lexicon Pharmaceuticals may also be known as or be related to LEXICON PHARMACEUTICALS INC., LEXICON PHARMACEUTICALS, INC., Lexicon Pharmaceuticals, Lexicon Pharmaceuticals Inc, Lexicon Pharmaceuticals, Inc and Lexicon Pharmaceuticals, Inc.